Zobrazeno 1 - 10
of 3 134
pro vyhledávání: '"J Baron"'
Publikováno v:
Echo Research and Practice, Vol 7, Iss 2, Pp K11-K16 (2020)
Transthoracic echocardiography (TTE) is widely used as a pre-operative screening tool. It can provide extensive information about cardiac function and underlying pathology, which could influence decisions regarding surgery. This patient was referred
Externí odkaz:
https://doaj.org/article/8f37d0ddec3f46dfaebe66384fffa8c3
Autor:
J Baron, W C Campbell, D DeMille, J M Doyle, G Gabrielse, Y V Gurevich, P W Hess, N R Hutzler, E Kirilov, I Kozyryev, B R O’Leary, C D Panda, M F Parsons, B Spaun, A C Vutha, A D West, E P West, ACME Collaboration
Publikováno v:
New Journal of Physics, Vol 19, Iss 7, p 073029 (2017)
We recently set a new limit on the electric dipole moment of the electron (eEDM) (J Baron et al and ACME collaboration 2014 Science 343 269–272), which represented an order-of-magnitude improvement on the previous limit and placed more stringent co
Externí odkaz:
https://doaj.org/article/6e0b328b78fe41e682633809b6958c6b
Publikováno v:
Bone & Joint Open, Vol 3, Iss 9, Pp 692-700 (2022)
AimsThe primary aim of our study was to assess the influence of age on hip-specific outcome following total hip arthroplasty (THA). Secondary aims were to assess health-related quality of life (HRQoL) and level of activity according to age.MethodsA p
Externí odkaz:
https://doaj.org/article/f5871e82891f4f01a23190c4d3425164
Publikováno v:
US Cardiology Review, Vol 16, Iss , Pp - (2022)
Transcatheter aortic valve replacement has transformed the paradigm of care for patients with severe aortic stenosis (AS). With transcatheter aortic valve replacement now commercially approved for AS patients of all surgical risk, clinical decision-m
Externí odkaz:
https://doaj.org/article/0ab23f767c7f4114a2c775d9e42c0cfd
Autor:
Alexandra Lansky, MD, FSCAI, Suzanne J. Baron, MD, MSc, Cindy L. Grines, MD, MSCAI, Jennifer A. Tremmel, MD, MS, FSCAI, Rasha Al-Lamee, MBBS, MA, PhD, FSCAI, Dominick J. Angiolillo, MD, PhD, FSCAI, Alaide Chieffo, MD, FSCAI, Kevin Croce, MD, FSCAI, Alice K. Jacobs, MD, MSCAI, Mina Madan, MD, MHS, FSCAI, Akiko Maehara, MD, FSCAI, Julinda Mehilli, MD, FSCAI, Roxana Mehran, MD, MSCAI, Vivian Ng, MD, FSCAI, Puja B. Parikh, MD, MPH, FSCAI, Jacqueline Saw, MD, FSCAI, J. Dawn Abbott, MD, FSCAI
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 1, Iss 2, Pp 100016- (2022)
Externí odkaz:
https://doaj.org/article/23f3c5a17e4c49d6b1570601f2591b23
Autor:
Mabel Chung, Neel M. Butala, Kamil F. Faridi, Zaid I. Almarzooq, Dingning Liu, Jiaman Xu, Yang Song, Suzanne J. Baron, Changyu Shen, Dhruv S. Kazi, Robert W. Yeh
Publikováno v:
American Heart Journal. 255:125-136
Days at home (DAH) quantifies time spent at home after a medical event but has not been fully evaluated for TAVR. We sought to compare 1- and 5-year DAH (DAHWe linked data from the U.S. CoreValve High Risk Trial to Medicare Fee-for-Service claims in
Autor:
S. Lonial, H.C. Lee, A. Badros, S. Trudel, A.K. Nooka, A. Chari, A-O. Abdallah, N.S. Callander, D.W. Sborov, A. Suvannasankha, K. Weisel, P.M. Voorhees, M. Hultcrantz, E.N. Libby, P.G. Richardson, P. Rodriguez Otero, B. Besemer, T. Facon, A. Hoos, J. Baron, T. Piontek, R.C. Jewell, E. Lewis, J. Opalinska, I. Gupta, A.D. Cohen, A. Medaglia
Publikováno v:
Hematology Reports, Vol 12, Iss s1 (2020)
Introduction: Belanatamab mafodotin (GSK2857916; belamaf; BLENREP) showed deep and durable single-agent activity in the pivotal DREAMM-2 study primary analysis (NCT03525678)(1–5) in a patient population that historically has a poor prognosis (overa
Externí odkaz:
https://doaj.org/article/b45ece96c95e4ce6b6696bd426b34a81
Autor:
A. Medaglia, A.D. Cohen, H.C. Lee, S. Trudel, A-O. Abdallah, N. Callander, E. Libby, L. Karlin, S. Lonial, L. Womersley, J. Baron, E. Lewis, K. Nungesser, I. Gupta, J. Opalinska
Publikováno v:
Hematology Reports, Vol 12, Iss s1 (2020)
Introduction: Single-agent belamaf (BLENREP) demonstrated deep and durable responses in the DREAMM-2 (NCT03525678) primary analysis(1) and long-term follow-up.(2,3) Keratopathy (microcyst-like epithelial changes [MECs] observed on eye examination wit
Externí odkaz:
https://doaj.org/article/b83a4fa7390040fdb481a63d7fe2ca47
Autor:
Suzanne J Baron
Publikováno v:
US Cardiology Review, Vol 14, Iss , Pp - (2020)
Treatment of secondary (or functional) mitral regurgitation had traditionally been limited to optimal medical therapy because studies have failed to show a survival benefit with mitral valve surgery for this condition. However, recently the Cardiovas
Externí odkaz:
https://doaj.org/article/e0e84d83a3ef428481b119afc5e50faf
Autor:
Richard J. Baron, Carl H. Coleman
Publikováno v:
New England Journal of Medicine. 388:676-678